---
schema_version: '1.0'
id: news-20260820-95f69e
title: mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck
  say
url: https://arstechnica.com/health/2026/08/mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say/
url_hash: 95f69e8106e9d9ab6708173dfdeeda3a034abb7dd2cb746a9d98d970c5be103f
canonical_url: https://arstechnica.com/health/2026/08/mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say
source: ArsTechnica
category: news/tech
category_raw: tech
region: usa
tags:
- it_general
- it_tech
- it_ai
lang: en
published_at: '2026-08-19T16:53:56Z'
fetched_at: '2026-08-20T04:18:29.178988Z'
updated_at: '2026-08-20T04:31:05Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- 10000 anti rabies vaccines
- and
- artificial intelligence
- cancer
- it_ai
- it_general
- it_tech
- melanoma
- Merck
- Moderna
- mRNA
- mRNA癌ワクチン
- Phase
- Phase3
- say
- succeeded
- technology
- TRIAL
- vaccine
entities_en:
- name: 10000 anti rabies vaccines
  type: data
- name: cancer
  type: naturalobject
- name: it_ai
  type: concept
- name: it_general
  type: concept
- name: it_tech
  type: concept
- name: mRNA癌ワクチン
  type: content
- name: Phase3
  type: event
- name: TRIAL
  type: organization
topics_en:
- artificial intelligence
- technology
numeric_facts: []
entities:
- name: mRNA癌ワクチン
  type: content
- name: cancer
  type: naturalobject
- name: 10000 anti rabies vaccines
  type: data
- name: Phase3
  type: event
- name: TRIAL
  type: organization
key_facts: []
related: []
related_auto:
- name: Ornith-1.5
  type: content
  weight: 1.0
- name: Unsloth Dynamic 3.0 GGUFs
  type: content
  weight: 1.0
- name: Robotax, トピック
  type: UNKNOWN
  weight: 1.0
- name: Cricut Maker
  type: artifact
  weight: 1.0
- name: ExtensibleSoftware
  type: concept
  weight: 1.0
computed_at: null
sanitized_at: '2026-08-20T14:56:50.092484+00:00'
---

# mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- it_general / it_tech / it_ai

## Details
(本文なし。リンク先参照)

## Source
元記事: [mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say](https://arstechnica.com/health/2026/08/mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say/) — published 2026-08-19T16:53:56Z